Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery

NCT06021457 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

454

Enrollment

INDUSTRY

Sponsor class

Conditions

Post-Operative Complications in Cardiac Surgery

Interventions

DRUG: RBT-1
DRUG: Placebo

Sponsor

Renibus Therapeutics, Inc.